Biomea Fusion(BMEA) - 2025 Q2 - Quarterly Results
2025-08-05 20:06
Exhibit 99.1 Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights SAN CARLOS, Calif., August 5, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. ("Biomea" or "Biomea Fusion" or "the Company") (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today reported its financial results for the second quarter ended June 30, 2025, and provided a business update. "In the second quarter, we presented clinical and preclinical results with icovamenib that support its unique role a ...
Douglas Dynamics(PLOW) - 2025 Q2 - Quarterly Report
2025-08-05 20:06
Table of Contents For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Commission file number: 001-34728 Form 10-Q DOUGLAS DYNAMICS, INC. (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) ...
Day One Biopharmaceuticals pany(DAWN) - 2025 Q2 - Quarterly Report
2025-08-05 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40431 DAY ONE BIOPHARMACEUTICALS, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 83-2415215 (State or othe ...
Myriad(MYGN) - 2025 Q2 - Quarterly Results
2025-08-05 20:06
Exhibit 99.1 Myriad Genetics Reports Second Quarter 2025 Financial Results; Raises 2025 Revenue Guidance Following Positive Business Momentum Highlights SALT LAKE CITY, August 5, 2025 – Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced financial results for its second quarter ended June 30, 2025 and updated its financial guidance on business performance for the full-year 2025. Attributable to UNH discontinuation of coverage (commercial and ...
Frontdoor(FTDR) - 2025 Q2 - Quarterly Report
2025-08-05 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________________________________ FORM 10-Q ________________________________________________ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-38617 Frontdoor, Inc. (Exact name of registran ...
Paysign(PAYS) - 2025 Q2 - Quarterly Results
2025-08-05 20:06
Exhibit 99.1 Earnings Release Paysign, Inc. Reports Second Quarter 2025 Financial Results Adjusted EBITDA and Adjusted EBITDA per share are non-GAAP metrics used by management to gauge the operating performance of the business – see reconciliation of net income to Adjusted EBITDA at the end of the press release. HENDERSON, Nev. – August 5, 2025 – (Business Wire) – Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive pharma patient affordability offerings, financial techno ...
Allison(ALSN) - 2025 Q2 - Quarterly Report
2025-08-05 20:06
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-35456 ALLISON TRANSMISSION HOLDINGS, INC. Table of Contents (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or Delaware 2 ...
Reservoir Media(RSVR) - 2026 Q1 - Quarterly Report
2025-08-05 20:06
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39795 RESERVOIR MEDIA, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction o ...
Clearway Energy(CWEN_A) - 2025 Q2 - Quarterly Results
2025-08-05 20:06
Clearway Energy, Inc. Reports Second Quarter 2025 Financial Results PRINCETON, NJ — August 5, 2025— Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) today reported second quarter 2025 financial results, including Net Income of $12 million, Adjusted EBITDA of $343 million, Cash from Operating Activities of $191 million, and Cash Available for Distribution (CAFD) of $152 million. "During the first half of this year, we made strong progress towards our near-term and long-term growth goals – demonstrating how our mul ...
Entravision(EVC) - 2025 Q2 - Quarterly Results
2025-08-05 20:06
Entravision Communications Page 1 of 6 Exhibit 99.1 BURBANK, CALIFORNIA, August 5, 2025 – Entravision Communications Corporation (NYSE: EVC), a media and advertising technology company, today announced financial results for its second quarter ended June 30, 2025. "While our Media segment net revenue decreased 8% compared to the second quarter of 2024, we're encouraged by the sequential improvement from the first quarter of 2025 and the achievement of positive operating profit, further validating our expande ...